Duke University
Durham, NC, United States
Dr. Sadun is a pediatric and adult rheumatologist and Assistant Professor at Duke University. After earning her MD and PhD from the Keck School of Medicine at the University of Southern California, she came to Duke for MedPeds residency followed by a combined adult and pediatric rheumatology fellowship. She currently sees patients with rheumatic diseases across the age spectrum. She currently conducts research on mRNA vaccine immunogenicity and safety in lupus.
Friday, November 10, 2023
3:45 PM – 4:05 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Friday, November 10, 2023
4:05 PM – 4:25 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Friday, November 10, 2023
4:25 PM – 4:45 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Friday, November 10, 2023
4:45 PM – 5:05 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Friday, November 10, 2023
5:05 PM – 5:25 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Transition of Care Concerns in JIA
Saturday, November 11, 2023
8:10 AM – 8:40 AM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
How to Start a Conversation About Mental Health in Rheumatology Clinic
Tuesday, November 14, 2023
8:10 AM – 8:20 AM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Group Breakout, Role Play and Discussion
Tuesday, November 14, 2023
8:40 AM – 9:20 AM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
Tuesday, November 14, 2023
9:50 AM – 10:00 AM PT
Disclosure(s): No financial relationships with ineligible companies to disclose
15W122: Genes, Gender, and Gammaglogulins in Severe COVID: Lessons Learned from the Pandemic
Wednesday, November 15, 2023
11:00 AM – 12:00 PM PT
Disclosure(s): No financial relationships with ineligible companies to disclose